SGP
SpyGlass Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$24.60
+2.50%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-24.1%
Return on equity
-23.0%
Return on assets
-26.5%
Return on invested capital
0.00x
Asset turnover
-$46.6M
Cash from operations
$7.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026